Please check your internet connection and try again.
# Miconazole Vaginal Pessary
## Overview
Miconazole is a synthetic imidazole antifungal agent that works by inhibiting the synthesis of ergosterol, a vital component of fungal cell membranes, leading to increased membrane permeability and cell death.
## Primary Indications
Treatment of vulvovaginal candidiasis (yeast infection).
## Adult Dosing
* **100 mg vaginal pessary:** Insert 1 pessary vaginally at bedtime for 7 days.
* **200 mg vaginal pessary:** Insert 1 pessary vaginally at bedtime for 3 days.
* **Combination package (1200 mg vaginal suppository):** Insert 1 suppository vaginally as a single dose.
## Pediatric Dosing
Data for pediatric use of miconazole vaginal pessaries is limited. Dosing should be guided by clinical judgment and may follow adult regimens for patients who have reached adult pharmacokinetic profiles. Consult with a pediatrician or infectious disease specialist for specific recommendations.
## Dose Adjustments
No dose adjustments are typically necessary for renal or hepatic impairment for vaginal administration.
## Contraindications
* Hypersensitivity to miconazole or any component of the formulation.
* Use with oral midazolam or simvastatin.
## Adverse Effects
Common:
* Vaginal burning, itching, or irritation
* Lower abdominal cramping or pain
Less Common:
* Headache
* Rash
## Key Drug Interactions
* **CYP3A4 Inhibitor:** Miconazole is a potent inhibitor of CYP3A4. Co-administration with CYP3A4 substrates (e.g., oral midazolam, simvastatin, cyclosporine, tacrolimus, some calcium channel blockers) can lead to significantly increased plasma concentrations of these drugs, potentially causing serious adverse effects. This interaction is most concerning with oral miconazole but can occur with vaginal formulations, especially with prolonged use or in cases of systemic absorption.
* **Warfarin:** Vaginal miconazole may increase the anticoagulant effect of warfarin. Monitor INR closely.
## Monitoring
* Monitor for signs and symptoms of vulvovaginal candidiasis.
* Monitor for local irritation or signs of hypersensitivity.
* If co-administered with warfarin, monitor INR.
## Clinical Pearls
* Complete the full course of therapy, even if symptoms improve sooner.
* Avoid intercourse during treatment as it may affect the pessary or partner.
* Oily vaginal preparations may weaken latex condoms.
* If pregnant, consult with a healthcare provider regarding the safest treatment option. The 7-day 100 mg regimen is often preferred in pregnancy.
***
_This information is intended for healthcare professionals. Always consult the most current prescribing information and institutional protocols before making clinical decisions. Dosing and recommendations may vary._
